BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 33080051)

  • 1. Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID-19.
    Rivera-Caravaca JM; Núñez-Gil IJ; Vivas D; Viana-Llamas MC; Uribarri A; Becerra-Muñoz VM; Trabattoni D; Fernández Rozas I; Feltes G; López-Pais J; El-Battrawy I; Macaya C; Fernandez-Ortiz A; Estrada V; Marín F;
    Eur J Clin Invest; 2021 Jan; 51(1):e13436. PubMed ID: 33080051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes.
    Rivera-Caravaca JM; Buckley BJR; Harrison SL; Fazio-Eynullayeva E; Underhill P; Marín F; Lip GYH
    Thromb Res; 2021 Sep; 205():1-7. PubMed ID: 34218058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
    Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
    Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Chronic Oral Anticoagulation and Associated Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.
    Secemsky EA; Butala NM; Kartoun U; Mahmood S; Wasfy JH; Kennedy KF; Shaw SY; Yeh RW
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry.
    Rivera-Caravaca JM; Núñez-Gil IJ; Lip GYH; Uribarri A; Viana-Llamas MC; Gonzalez A; Castro-Mejía AF; Alonso González B; Alfonso E; García Prieto JF; Cavallino C; Cortese B; Feltes G; Fernández-Rozas I; Signes-Costa J; Huang J; García Aguado M; Pepe M; Romero R; Cerrato E; Becerra-Muñoz VM; Raposeiras Roubin S; Santoro F; Bagur R; Sposato L; El-Battrawy I; López Masjuan A; Fernandez-Ortiz A; Estrada V; Macaya C; Marín F
    Int J Clin Pract; 2022; 2022():7325060. PubMed ID: 35685504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID-19: Insight From a French Multicenter Cohort Study.
    Chocron R; Galand V; Cellier J; Gendron N; Pommier T; Bory O; Khider L; Trimaille A; Goudot G; Weizman O; Alsac JM; Geneste L; Schmeltz A; Panagides V; Philippe A; Marsou W; Ben Abdallah I; Deney A; El Batti S; Attou S; Juvin P; Delmotte T; Messas E; Pezel T; Planquette B; Duceau B; Gaussem P; Sutter W; Sanchez O; Waldman V; Diehl JL; Mirault T; Bonnet G; Cohen A; Smadja DM;
    J Am Heart Assoc; 2021 Apr; 10(8):e018624. PubMed ID: 33550816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks associated with prior oral anticoagulation use in hospitalized COVID-19 patients - A retrospective cohort study on 5392 patients from a tertiary centre.
    Bistrovic P; Sabljic A; Kovacevic I; Cikara T; Keres T; Lucijanic T; Mitrovic J; Delic-Brkljacic D; Manola S; Lucijanic M
    Int J Cardiol; 2023 Feb; 372():144-149. PubMed ID: 36471534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-medication with oral anticoagulants is associated with better outcomes in a large multinational COVID-19 cohort with cardiovascular comorbidities.
    Rieder M; Gauchel N; Kaier K; Jakob C; Borgmann S; Classen AY; Schneider J; Eberwein L; Lablans M; Rüthrich M; Dolff S; Wille K; Haselberger M; Heuzeroth H; Bode C; von Zur Mühlen C; Rieg S; Duerschmied D
    Clin Res Cardiol; 2022 Mar; 111(3):322-332. PubMed ID: 34546427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and Atrial Fibrillation in Older Patients: Does Oral Anticoagulant Therapy Provide a Survival Benefit?-An Insight from the GeroCovid Registry.
    Fumagalli S; Trevisan C; Del Signore S; Pelagalli G; Volpato S; Gareri P; Mossello E; Malara A; Monzani F; Coin A; Bellelli G; Zia G; Antonelli Incalzi R;
    Thromb Haemost; 2022 Jan; 122(1):105-112. PubMed ID: 33962480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study.
    Tomasoni D; Inciardi RM; Lombardi CM; Tedino C; Agostoni P; Ameri P; Barbieri L; Bellasi A; Camporotondo R; Canale C; Carubelli V; Carugo S; Catagnano F; Dalla Vecchia LA; Danzi GB; Di Pasquale M; Gaudenzi M; Giovinazzo S; Gnecchi M; Iorio A; La Rovere MT; Leonardi S; Maccagni G; Mapelli M; Margonato D; Merlo M; Monzo L; Mortara A; Nuzzi V; Piepoli M; Porto I; Pozzi A; Sarullo F; Sinagra G; Volterrani M; Zaccone G; Guazzi M; Senni M; Metra M
    Eur J Heart Fail; 2020 Dec; 22(12):2238-2247. PubMed ID: 33179839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and the impact of arterial hypertension-An analysis of the international HOPE COVID-19 Registry (Italy-Spain-Germany).
    El-Battrawy I; Nuñez-Gil IJ; Abumayyaleh M; Estrada V; Manuel Becerra-Muñoz V; Uribarri A; Fernández-Rozas I; Feltes G; Arroyo-Espliguero R; Trabattoni D; López-País J; Pepe M; Romero R; Castro-Mejía AF; Cerrato E; Capel Astrua T; D'Ascenzo F; Fabregat-Andres O; Signes-Costa J; Marín F; Buonsenso D; Bardají A; Jesús Tellez M; Fernández-Ortiz A; Macaya C; Akin I
    Eur J Clin Invest; 2021 Nov; 51(11):e13582. PubMed ID: 34409593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data.
    Kushnir M; Choi Y; Eisenberg R; Rao D; Tolu S; Gao J; Mowrey W; Billett HH
    Lancet Haematol; 2019 Jul; 6(7):e359-e365. PubMed ID: 31133411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes and the impact of prior oral anticoagulant use in patients with coronavirus disease 2019 admitted to hospitals in the UK - a multicentre observational study.
    Arachchillage DJ; Rajakaruna I; Odho Z; Crossette-Thambiah C; Nicolson PLR; Roberts LN; Allan C; Lewis S; Riat R; Mounter P; Lynch C; Langridge A; Oakes R; Aung N; Drebes A; Dutt T; Raheja P; Delaney A; Essex S; Lowe G; Sutton D; Lentaigne C; Sayar Z; Kilner M; Everington T; Shapiro S; Alikhan R; Szydlo R; Makris M; Laffan M
    Br J Haematol; 2022 Jan; 196(1):79-94. PubMed ID: 34500500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF.
    Verheugt FWA; Ambrosio G; Atar D; Bassand JP; Camm AJ; Costabel JP; Fitzmaurice DA; Illingworth L; Goldhaber SZ; Goto S; Haas S; Jansky P; Kayani G; Stepinska J; Turpie AGG; van Eickels M; Kakkar AK;
    Am J Med; 2019 Dec; 132(12):1431-1440.e7. PubMed ID: 31306621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
    JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-Operative Continued Oral Anticoagulation Impact on Early Outcomes after Transcatheter Aortic Valve Implantation.
    Tagliari AP; Perez-Camargo D; Ferrari E; Haager PK; Jörg L; Gennari M; Chen M; Gavazzoni M; Khattab AA; Blöchlinger S; Maisano F; Taramasso M
    Am J Cardiol; 2021 Jun; 149():64-71. PubMed ID: 33757781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
    Kreidieh F; Temraz S
    Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients.
    Rivera-Caravaca JM; Roldán V; Esteve-Pastor MA; Valdés M; Vicente V; Lip GYH; Marín F
    Thromb Haemost; 2017 Jun; 117(7):1448-1454. PubMed ID: 28331926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Chronic Treatment with Oral Anticoagulants Ameliorate the Clinical Course of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Coronavirus Disease 2019 (COVID-19)?
    Harenberg J; Bauersachs R; Ageno W
    Semin Thromb Hemost; 2021 Jun; 47(4):338-340. PubMed ID: 32882715
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of atrial fibrillation in critically ill patients admitted to a stepdown unit.
    Falsetti L; Proietti M; Zaccone V; Guerra F; Nitti C; Salvi A; Viticchi G; Riccomi F; Sampaolesi M; Silvestrini M; Moroncini G; Lip GYH; Capucci A
    Eur J Clin Invest; 2020 Nov; 50(11):e13317. PubMed ID: 32535903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.